• SELECT SITE CURRENCY
Select a currency for use throughout the site
Global Tissue Engineering and Regeneration Market 2011-2015
Infiniti Research Limited, February 2012, Pages: 37
TechNavio’s analysts forecast the Global Tissue Engineering and Regeneration market to grow at a CAGR of 8.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is increased applications in the Skin Integumentary Clinical segment. The Global Tissue Engineering and Regeneration market has also been witnessing new regulations for regenerative medicines in Europe. However, lack of specialists in the market could pose a challenge to the growth of this market.
TechNavio’s report, Global Tissue Engineering and Regeneration Market 2011–2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Tissue Engineering and Regeneration market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Stryker Corp., Zimmer Inc., Medtronic Inc., DePuy Inc., and Baxter International Inc.
Key questions answered in this report:
What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
TechNavio Announces the Publication of its Report – Global Tissue Engineering and Regeneration Market 2011–2015
TechNavio today launched its report Global Tissue Engineering and Regeneration Market 2011–2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the key trends impacting the growth of this market.
Commenting on the report, an analyst from Healthcare team said, “The cost of managing a number of chronic conditions of the skin, such as decubitus, has initiated a strong demand for technologies that can accelerate healing. There are an estimated 1.1 million victims with burnt skin in the US who can benefit from cell-based therapy. Moreover, it is estimated that more than 15 percent of diabetic patients are developing foot ulcers worldwide. Skin/integumentary application has been established as a technology proving ground in the Global Tissue Engineering and Regeneration market.”
According to the report, the Global Tissue Engineering and Regenerative market is experiencing an increase in mergers and acquisitions. There has been significant increase in the acquisition of small and medium-sized companies by the leading tissue engineering and regenerative medicine developers. For example, Eli Lilly & Co. hs partnered with Medtronic Inc. in 2011 for treating disease with a new drug delivery system for the brain.
The report also discusses key challenges impacting this market including low awareness levels in some developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
01. Executive Summary
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Stryker Corp.
14.2 Zimmer Inc.
14.3 Medtronic Inc.
14.4 DePuy Inc.
14.5 Baxter International Inc.
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Tissue Engineering and Regeneration Market 2011–2015 (US$ billion)
Exhibit 2: Global Tissue Engineering and Regeneration Market by Clinical Category Segmentation 2011
Exhibit 3: Global Tissue Engineering and Regeneration Market by Geographical Segmentation 2011
Exhibit 4: Global Tissue Engineering and Regeneration Market by Vendor Segmentation 2011